dG Medical Group holds the distributorship for Regenerative Protein Array (RPA) for clinical/medical data collection purposes.
We partner with local Medical Research Institutions to perform innovative research on the regenerative properties of Regenerative Protein Arrays (RPA) and their contents. This new form of regenerative medicine has been in development for years and dG Medical Group has partnered as the strategic distributorship which can now be legally sold for clinical use.
Regenerative Protein Arrays (RPA) contain large amounts of growth factors, cytokines, and other substances with high regenerative potential that can be transferred to other cells due to their unique structure.
This structure allows Regenerative Protein Arrays to fuse with cells in the body and to release their content into other cells. The contents of the Regenerative Protein Array can then help the cell heal itself due to the actions of the transferred signaling molecules.
Regenerative Protein Arrays (RPA) have been shown to be the source of healing and regeneration. The process by which RPA regeneration works to heal the body is as follows:
An injured tissue releases chemical markers signaling their damage > these markers are absorbed and create the appropriate components for healing the tissue > the RPA packages these components > RPAs go to the site of injured tissue and attach> then release their contents to the injured tissue, healing the tissue. Regenerative Protein Arrays (RPA) have been shown to be efficacious in a number of studies related to repair of peripheral nerve damage, traumatic brain injury, accelerated wound healing and bone fusion, tissue repair, anti-inflammatory effects, skin regeneration, cartilage regeneration, treatment for injured ligaments/tendons, osteoarthritis, bone regeneration, and vaginal rejuvenation.
Regenerative Protein Arrays (RPA) is a new frontier in Regenerative medicine. and stands at the forefront of medical innovation, aiming to restore the structure and function of damaged tissues and organs. Among the numerous breakthroughs in this field, regenerative protein arrays have emerged as a revolutionary tool, offering promising avenues for healing and regeneration. This article explores how placenta-derived protein arrays are utilized in regenerative medicine, the conditions they help alleviate, and the measurable outcomes that underscore their potential.
Regenerative Protein Arrays (RPA) is a new frontier in Regenerative Medicine. Regenerative medicine stands at the forefront of medical innovation, aiming to restore the structure and function of damaged tissues and organs. Among the numerous breakthroughs in this field, regenerative protein arrays have emerged as a revolutionary tool, offering promising avenues for healing and regeneration. This article explores how regenerative protein arrays are utilized in regenerative medicine, the conditions they help alleviate, and the measurable outcomes that underscore their potential.
The placenta, once considered mere biological waste post-birth, is now recognized as a powerhouse of regenerative potential. Rich in growth factors, cytokines, and hormones, placental proteins are key players in cell signaling, immune responses, and tissue repair. Regenerative protein arrays organize these proteins systematically, allowing for detailed study and application in regenerative therapies.
Regenerative protein arrays are carving a niche in regenerative medicine, offering hope and healing where traditional treatments fall short. By unlocking the regenerative secrets of placental proteins, these arrays are contributing to advancements in wound care, bone regeneration, and neuro-regeneration.
D & G Medical Group Inc.
15500 Roosevelt Blvd.
Clearwater, FL 33760
Contact by Phone:
+1 (855) 320-7559
Contact by email:
info@dgmedicalgroup.com
© 2023 | dG Medical Group, Inc. Designed and Powered by Advanced Creative Group
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.